COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Community
The National Organization for Rare Disorders (NORD), along with The ALS Association, Cystic Fibrosis Foundation and Muscular Dystrophy Association, is pleased to host a special webinar with leaders from the US Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) to discuss the COVID-19 vaccines with the rare disease community. FDA recently granted Emergency Use Authorization (EUA) for the Pfizer and Moderna COVID-19 vaccines.
Questions that will be addressed include:
- What do the EUAs of these vaccines mean for the rare disease community?
- When might other vaccines receive an EUA?
- Are there special considerations for the rare disease community with respect to the COVID-19 vaccines?
- What role does CDC play with respect to vaccines?
Additional questions from members of the rare community will be collected during the registration period and addressed in the live webinar.
This webinar is intended for patients, caregivers, advocates and the general public.
*To view the webinar click here to register for on-demand video access.